Composition containing monoclonal antibody
AssigneeIgalphan corporation
InventorsReiko Shinkura, Keiko Iwaisako
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a pharmaceutical composition, a food composition, or a feed composition containing a monoclonal antibody that binds to enteric bacteria and used for preventing or treating an impairment or disease attributed to liver inflammation, and a therapeutic method using these compositions.
Claims8
A pharmaceutical composition, a food composition, or a feed composition comprising a monoclonal antibody that binds to enteric bacteria or an antigen-binding fragment thereof,
- wherein the pharmaceutical composition, the food composition, or the feed composition is used for preventing or treating an impairment or disease attributed to liver inflammation.
A method for preventing or treating an impairment or disease attributed to liver inflammation, the method comprising administering a monoclonal antibody that binds to enteric bacteria to a subject in need of prevention or treatment of an impairment or disease attributed to liver inflammation.
Dependencies are inferred from the claim text.